日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series

更正:从既往抗CD20单克隆抗体治疗转换为ublituximab治疗:病例报告系列

Berkovich, Regina; Calkwood, Jonathan; Crayton, Heidi; Erwin, April; Faissner, Simon; Gold, Ralf; Katz, Joshua; Leekoff, Mark

Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series

从既往抗CD20单克隆抗体治疗转换为ublituximab治疗:病例报告系列

Berkovich, Regina; Calkwood, Jonathan; Crayton, Heidi; Erwin, April; Faissner, Simon; Gold, Ralf; Katz, Joshua; Leekoff, Mark